Valuation: Brooks Laboratories Limited

Market Cap 1.76B 18.53M 16.62M 15.37M 13.92M 26M 26.32M 184M 73.19M 923M 69.52M 68.06M 2.93B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.78B 18.72M 16.8M 15.53M 14.06M 26.27M 26.59M 186M 73.95M 933M 70.25M 68.77M 2.96B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
45.16%
Yield 2025 *
-
Yield 2026 -
09-16 Brooks Laboratories Limited Announces Resignation of Krutika Rane as Company Secretary and Compliance Officer (Key Managerial Personnel), Effective October 9, 2026 CI
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-19 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-07 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
1 day+0.30%
1 week-1.45%
Current month+7.35%
1 month+5.92%
3 months-4.54%
6 months-3.04%
Current year-25.26%
1 week 55.5
Extreme 55.5
62.89
1 month 52.97
Extreme 52.97
75.6
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
116
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 23/01/2002
Chief Executive Officer - 01/06/2026
President 58 23/08/2023
Director TitleAgeSince
Director/Board Member 53 23/11/2022
Director/Board Member 62 10/09/2010
Director/Board Member - 23/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%-1.45%-43.90%-42.98% 18.52M
+0.50%+1.38%+57.09%+129.96% 1,143B
+0.86%+5.14%+45.00%+86.15% 647B
-0.14%+0.42%+25.69%+105.85% 506B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 350B
+0.34%+1.84%+30.70%+54.27% 293B
-0.45%+1.19%+2.89%+26.08% 265B
+0.87%+3.08%+54.69%+72.74% 242B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.17%-0.06%+32.19%+64.47% 402.76B
Weighted average by Cap. +0.25%+0.71%+44.50%+89.02%

Financials

2025 2026
Net sales 826M 8.67M 7.78M 7.19M 6.51M 12.17M 12.31M 85.97M 34.24M 432M 32.53M 31.84M 1.37B 857M 9M 8.08M 7.47M 6.76M 12.63M 12.79M 89.28M 35.56M 449M 33.78M 33.07M 1.42B
Net income -99.67M -1.05M -939K -868K -786K -1.47M -1.49M -10.38M -4.13M -52.16M -3.93M -3.84M -166M 246M 2.58M 2.32M 2.14M 1.94M 3.62M 3.67M 25.6M 10.2M 129M 9.69M 9.48M 408M
Net Debt 75.39M 792K 710K 657K 595K 1.11M 1.12M 7.85M 3.13M 39.45M 2.97M 2.91M 125M 18.44M 194K 174K 161K 145K 272K 275K 1.92M 765K 9.65M 726K 711K 30.63M
Projected Income Statement - Annual - Brooks Laboratories Limited
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
28/10/26 ₹59.90 +0.30% 23,697
27/10/26 ₹59.72 +3.21% 24,757
26/10/26 ₹57.86 0.00% 53,859
23/10/26 ₹57.86 -5.29% 99,200
22/10/26 ₹61.09 +0.51% 54,438
  1. Stock Market
  2. Stocks
  3. BROOKS Stock